Médecins Sans Frontières is an international independent medical-humanitarian organization, which offers assistance to populations in distress, to victims of natural or man-made disasters and to victims of armed conflict, without discrimination and irrespective of race, religion, creed or political affiliation.
MSF is a civil society initiative that brings together individuals committed to the assistance of other human beings in crisis. As such MSF is by choice an association.
Each individual working with MSF does it out of conviction and is ready to uphold the values and principles of MSF.
The MSF movement is built around five operational directorates supported by MSF’s 21 sections, 24 associations and other offices together worldwide. MSF OCBA is one of those directorates. The operations are implemented by field teams and the mission coordination teams; together with the organizational units based in Barcelona, Athens and decentralised in Nairobi, Dakar and Amman. The field operations are guided and supported by 5 Operational Cells, the Emergency Unit and other departments supporting operations, including the Medical department.
CONTEXT OF THE POST
Many achievements have been accomplished by MSF treating HIV and tuberculosis (TB) in resources-limited setting in the last 20 years, demonstrating that providing care for People Living with HIV (PLWHA) and TB in humanitarian emergencies is feasible and that can reach good treatment outcomes.
In 2014, MSF movement confirmed its commitment towards HIV, with a special focus in integration of HIV/TB activities in projects with other medical priorities . Following the HIV/TB Road Map , MSF OCBA became the leading section in terms of integrating HIV and TB services within other medical priorities not necessarily related to HIV or TB prevalence, but to patient needs. MSF OCBA seeks to pursue integration of HIV/TB activities in humanitarian emergencies when relevant, within sexual and reproductive health (SRH), Paediatric and Nutritional projects. Besides the Missions where those components have been already implemented, the roadmap foresees the integration in some key countries where the projects are already running and that are among the lowest ART coverages in the world according to UNAIDS, such as CAR, DRC, Niger, Sudan, South Sudan or Nigeria.
With regards to TB, MSF re-affirmed its commitment to TB care in 2017 through a political statement: ‘Until 2025, every patient presenting with any form of TB in any MSF project will access simple and reliable diagnostics, as well as effective and well-tolerated treatment’ that emphasises striving to provide effective care for TB patients in all situations, including conflict settings, with specific attention to the most vulnerable populations (children and adolescents, HIV-infected patients, prisoners, displaced people, migrants). TB care should include DR-TB and the use of short course MDR-TB regimens as per current international recommendations 
In 2016, MSF issued an intersectional Policy for the management of chronic Hepatitis B&C  in which the organization confirmed its engagement towards the prevention, diagnosis and treatment of chronic viral hepatitis. According to WHO, an estimation of 240 million people are chronically infected with hepatitis B and more than 780 000 people die every year due to complications, such as cirrhosis and liver cancer . Effective vaccine and inexpensive chronic treatment are available but barely accessible: less than 5% of people living with chronic viral hepatitis know their status and less than 1% are receiving treatment . According to MSF OCBA blood bank data, in 2017 the hepatitis B positivity in African missions was 17% : an estimation of 20% among them is already in need of chronic treatment.
GENERAL OBJECTIVE OF THE POSITION
The HIV, TB & Hepatitis B Mobile Implementation Officer (MIO) position has been created to support missions and field teams to develop, implement and/or improve existing, HIV, TB and Hepatitis B activities in the projects. The main responsibilities will be to visit prioritized missions, couch and train field teams, and support the implementation of effective program activities.
Placement within the Organisational Chart:
The HIV, TB & Hepatitis B MIO is hierarchically accountable to the Head of Operational Medical Unit (HOMU). S/he is functionally linked to the HIV/TB/Hepatitis B&C Referent Advisor of the Medical Department. S/he works closely with the correspondent Operational Cell-based Health Advisor (TESACO) when implementing work for /in specific missions. While in mission on the field, s/he works under the regular hierarchical and functional structures of the missions, while keeping its communication with the Medical Department as explained above.
RESPONSIBILITIES AND MAIN TASKS
- The main task is to assist and support the field in the implementation of HIV/TB/Hepatitis B program activities as a direct implementer and as part of the field team, in line with the projects operational objectives. The implementation will take place in identified priority missions (Sudan, Ethiopia, CAR, Niger, Nigeria)
- Visit planning and specific Terms of reference (ToR) for the visits will be done by the Medical Teams of each Mission in collaboration with TESACOS, HOMU and HIV/TB Referent. The ToR can include several of the tasks below or others according to identified needs:
- Assist in identification of needs, gaps in existing programming (MoH, MSF, or other actors), formulation of proposal for an intervention strategy of MSF-OCBA in line with a specific context
- Assist and support field teams in the practical implementation of program activities agreed by the Operational Cell.
- Analyse and provide advice on the adequacy of medical diagnosis and therapeutic approaches, as well as therapeutic guidelines, kits or drugs used in the projects, as well as formulation of medical and supply orders, health promotion / community engagement and counselling needs and strategies, implementation of M&E systems, flow of patients, etc.
- Assist MCT in interaction with local and national authorities, mapping of other players, etc.
- Provide trainings in the field (medical and non-medical, national, international, and MoH staff) concerning the implementation of the HIV/TB/Hepatitis B activities; with a strong focus on implementation procedures, diagnostic and treatment protocols, tools, correct and timely data collection, supervision and data collection and analysis.
- The MIO will mentor and coach either a national or international staff in charge of this particular activity (PMR, Flying, MAM, national medical responsible, etc.) with the main objective of capacity building to ensure the continuation of the HIV/TB/Hepatitis B activity
- Participate and support in data analysis at project level, including quality of data in line lists and HMIS
- Capitalize and share field experiences as “lessons learnt” to improve HIV/TB/Hepatitis B health care practices whenever needed
- Each Mission visit will be followed by an Implementation Report within the following 3 weeks maximum. Inside some indicators will be provided to facilitate the progress check-up of the status and quality of the integration of HIV, TB and Hepatitis B components.
When the MIO is not working within a mission and after his/her rest and/or holiday periods, s/he may be asked to:
- Participate in training sessions (SAMU training, PPD/MMC/PMR and HoM/Medco co-days and others on request) and other national and international events as required.
- Participate in meetings at Medical department and service level as well as in other in-house discussion forums.
- Participate and/or animate thematic forums/collaborative platforms and medical seminars concerning chronic and infectious diseases.
Education and experience
• Required profile: Medical Doctor
• Field experience with MSF, or similar organization (at least 1 year in HIV/TB/Hepatitis programs)
• Practical field experience in the implementation of HIV, TB & Hepatitis B activities in developing countries, including training of personnel
• Experience in integrated programmes and unstable settings is an asset
• Experience with Non communicable diseases (NCDs) is an asset
• Familiar with MSF HIV, TB & Hepatitis guidelines and standards of care
• Languages: Fluent in written and spoken English, high level of spoken and written French. Spanish and Portuguese are considered as an asset
• Good computer skills (Microsoft Office, HMIS, Epi data)
- Commitment to MSF’s Principles
- Cross-cultural Awareness
- Behavioural Flexibility
- Analytical Thinking
- Strategic Vision
- Results and Quality Orientation
- Service Orientation
- Initiative and Innovation
- Teamwork and Cooperation
• Willingness to travel at short notice to whatever context MSF is working in, for missions in principle not exceeding 2 months
- Based in home country with frequent travelling and supervisions to the projects (80% of his/her working time)
- Contract: determined period 6 months
- Full time work
- Annual Gross salary: 26,981.28 euros (divided in 12 monthly payments) + Secondary benefits based on MSF OCBA Reward Policy.
- Practical working conditions while in the field are as per the MSF-OCBA guideline
- Starting date: March 2019
HOW TO APPLY
- To apply, all applicants should please send their CV and cover motivation letter under the reference “MIO TB, HIV & Hepatitis B Mobile Implementation Officer” to email@example.com
- Please submit your CV and cover letter in ONE file and name the file with your LAST NAME.
- Closing date: 11/02/2019
- Replies will only be sent to short-listed candidates.
- Médecins Sans Frontieres, as a responsible employer, under article 38 of “Ley de Integración Social del Minusválido de 1982 (LISMI)” invite those persons with a recognized disability and with an interest in the humanitarian area to apply for the above mentioned position.
 HIV strategic framework 2014-2017 (under revision)
 MSF OCBA HIV/TB Road map 2014-2017
 MSF Political statement on TB, September 2017
 MSF policy for the management of chronic hepatitis B & C, 2016
 WHO Factsheet on hepatitis B : http://www.who.int/mediacentre/factsheets/fs204/en/
 WHO, Draft Global Health Sector strategy-Viral Hepatitis-2016-2021: http://www.who.int/reproductivehealth/Hepatitis-global-strategy_Nov2015.pdf?ua=1
 HIV/TB/Hepatitis B&C annual report MSF OCBA 2017